Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PEB market cap is 93.3M. The company's latest EPS is NZD -0.0364 and P/E is -3.02.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Revenue | 4.95M | 10.09M | 13.14M | 21.03M | 25.23M |
| Operating Income | -19.1M | -14.54M | -20.51M | -32.04M | -33.58M |
| Net Income | -18.89M | -14.22M | -19.79M | -26.97M | -29.54M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Assets | 19.33M | 31.18M | 115.28M | 90.91M | 65.45M |
| Total Liabilities | 4.82M | 6.08M | 6.91M | 8.15M | 10.83M |
| Total Equity | 14.5M | 25.11M | 108.38M | 82.76M | 54.62M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Operating | -15.39M | -13.57M | -17.55M | -25.58M | -25.75M |
| Investing | -5.21M | -6.35M | -52.13M | 22.47M | 22.19M |
| Financing | 17.65M | 22.21M | 100.66M | -1.28M | -1.11M |
| Market Cap | 93.3M |
| Price to Earnings Ratio | -3.02 |
| Price to Sales Ratio | 3.54 |
| Price to Cash Ratio | 1.77 |
| Price to Book Ratio | 1.63 |
| Dividend Yield | - |
| Shares Outstanding | 811.27M |
| Average Volume (1 week) | 4.22k |
| Average Volume (1 Month) | 5.85k |
| 52 Week Change | 18.56% |
| 52 Week High | 0.18 |
| 52 Week Low | 0.07 |
| Spread (Intraday) | 0.03 (17.86%) |
| Company Name | Pacific Edge Limited |
| Address |
anderson lloyd dunedin |
| Website | https://www.pacificedge.co.nz |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
